Cst might now be able to start being charted from here.Previous attempts have had a fair amount of LSD abuse involved, one could say.
I see AHH have had a buy out offer, nice to see they supported holders via buyback and now the share price might double.
CST directors had a excellent opportunity to do the same but they proved lame
Wheres the revised CDC and Nippon approval?
Regards,